Short‐peptide fusion inhibitors with high potency against wild‐type and enfuvirtide‐resistant HIV‐1-Reference-Cited by-同舟云学术

Short‐peptide fusion inhibitors with high potency against wild‐type and enfuvirtide‐resistant HIV‐1

Published:2012-12-11 Issue:3 Volume:27 Page:1203-1213
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Chong Huihui¹,Yao Xue¹,Qiu Zonglin¹,Sun Jianping¹,Zhang Meng¹,Waltersperger Sandro²,Wang Meitian²,Liu Shan‐Lu³,Cui Sheng¹,He Yuxian¹

Affiliation:

1. MOH Key Laboratory of Systems Biology of Pathogens and AIDS Research CenterInstitute of Pathogen BiologyChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina

2. Swiss Light SourcePaul Scherrer InstituteVilligenSwitzerland

3. Department of Molecular Microbiology and ImmunologyUniversity of MissouriColumbiaMissouriUSA

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.12-222547

Reference44 articles.

1. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.

2. HIV-1 inhibition by a peptide

3. A Synthetic Peptide from HIV-1 gp41 Is a Potent Inhibitor of Virus-Mediated Cell—Cell Fusion

4. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.

5. Core Structure of gp41 from the HIV Envelope Glycoprotein

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of novel HIV fusion-inhibitory lipopeptides with the M-T hook structure;Microbes and Infection;2024-05

2. Antiviral Protein–Protein Interaction Inhibitors;Journal of Medicinal Chemistry;2024-02-23

3. Peptide–Drug Conjugates: An Emerging Direction for the Next Generation of Peptide Therapeutics;Journal of Medicinal Chemistry;2024-01-26

4. Helical sulfonyl-γ-AApeptides for the inhibition of HIV-1 fusion and HIF-1α signaling;RSC Medicinal Chemistry;2024

5. Fusion peptide induced modification of membrane organization and dynamics: Implications in developing fusion inhibitors;Chemical Physics Impact;2023-12